Bio-Techne Corporation

10 days ago · zacks.com

Techne (TECH) reported earnings 30 days ago. What's next for the stock?

11 days ago · seekingalpha.com

CMB.TECH delivered a 134% return in under a year, driven by a strategic dry bulk focus and strong tanker markets. I recently interviewed the CEO and CFO to get updates on the dry bulk industry and company-specific strategy. CMBT maintains a flexible, discretionary dividend policy, targeting 50–60% of net income over time while preserving capital for counter-cyclical opportunities.

14 days ago · globenewswire.com

ANTWERP, Belgium, 8 September 2026, 08:00 a.m. CET – CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) (“CMB.TECH” or the “Company”) (NYSE: CMBT, Euronext Brussels: CMBT en Euronext Oslo Børs: CMBTO) invites its shareholders to participate in the Special General Meeting that will be held on Thursday 8 October 2026.

20 days ago · prnewswire.com

Fiscal 2026 highlights: Science Based Targets initiative validates Bio-Techne's Scope 1, 2 and 3 greenhouse gas reduction targets Market-based Scope 1 and 2 emissions reduced 49% year-over-year More than half of the company's electricity consumption now comes from renewable sources First comprehensive Scope 3 emissions inventory completed MINNEAPOLIS, Sept. 1, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced significant progress toward its climate and sustainability objectives, including validation of its greenhouse gas reduction targets by the Science Based Targets initiative (SBTi) and substantial reductions in operational emissions during fiscal year 2026.

24 days ago · seekingalpha.com

CMB.TECH (CMBT) shows improved earnings quality as core shipping EBITDA rises despite reduced ship sales. Q2 revenue and EBITDA surged, but backlog growth stalled, raising concerns about long-term contract momentum. A strategic ammonia-powered vessel agreement with Fortescue signals tangible progress in clean fuel initiatives.

25 days ago · seekingalpha.com

CMB.TECH NV (CMBT) Q2 2026 Earnings Call Transcript

25 days ago · marketbeat.com

CMB.TECH NYSE: CMBT reported second-quarter 2026 net profit of $364.4 million, supported by revenue of more than $700 million and $127 million in gains from vessel sales, as shipping markets remained strong across several of the company's operating segments.

26 days ago · globenewswire.com

ANTWERP, Belgium, 27 August 2026 – CMB.TECH NV (“CMBT”, “CMB.TECH” or “the company”) (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO) reported its unaudited financial results today for the second quarter ended 30 June 2026.

1 month ago · zacks.com

Bio-Techne's Q4 revenues beat estimates as Diagnostics and Spatial Biology deliver strong organic growth, while its Merck deal remains in focus.

1 month ago · prnewswire.com

MINNEAPOLIS, Aug. 13, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) is issuing a correction to its dividend announcement released yesterday. The initial version incorrectly stated the shareholder of record date as August 17, 2026.